XOMA (XOMAP) Expected to Announce Quarterly Earnings on Thursday

XOMA (NASDAQ:XOMAP – Get Free Report) is expected to post its results before the market opens on Thursday, March 5th. Analysts expect XOMA to post earnings of ($0.11) per share and revenue of $11.13 million for the quarter.

XOMA Trading Up 0.1%

Shares of XOMAP stock opened at $25.77 on Wednesday. XOMA has a fifty-two week low of $24.96 and a fifty-two week high of $30.00. The stock has a 50 day moving average price of $26.34 and a two-hundred day moving average price of $26.41.

XOMA Company Profile

(Get Free Report)

XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.

Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.

Read More

• Five stocks we like better than XOMA
• New Copper-Rich “Kraken” Zone Discovered
• Silver Is the New Oil—And the World’s Running Dry
• America’s 1776 happening again
• 3 Signs You May Want to Switch Financial Advisors
• Silver’s squeeze is tightening – opportunity forming